This is a promotional website intended for UK Healthcare Professionals. For other UK residents, please visit www.astrazeneca.co.uk.
AstraZeneca aims to help you in supporting your respiratory patients
Prescribing and adverse event reporting information found at the bottom of the page.
Select the option you are interested in today:
- Register for updates
- Request a representative
Form Loading...
Thank you for joining our mailing list.
We have received your request and will be in touch with you soon.
Respiratory products
Links to prescribing and adverse event reporting information at bottom of the page.
Prescribing information
Symbicort (budesonide/formoterol) Asthma Prescribing Information
Symbicort (budesonide/formoterol) 200/6 and 400/12 COPD Prescribing Information
Tezspire ▼ (tezepelumab) Great Britain Prescribing Information
Tezspire ▼ (tezepelumab) Northern Ireland Prescribing Information
Fasenra (benralizumab) Great Britain Prescribing Information
Fasenra (benralizumab) Northern Ireland Prescribing Information
This website is intended for UK healthcare professionals only
© AstraZeneca 2023. All rights reserved.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.goc.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.
GB-50307 November 2023
© AstraZeneca 2023. All rights reserved.